Hepatitis B: The virus and disease

Hepatology

Volumn 49, Issue SUPPL. 5, 2009, Pages

  Liang, T Jake ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC HEPATITIS; DISEASE COURSE; DNA VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; MORBIDITY; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PATIENT MONITORING; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; RETROVIRUS; SEROLOGY; SYMPTOM; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS REPLICATION; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; GENETICS; GROWTH, DEVELOPMENT AND AGING; PATHOPHYSIOLOGY; VIROLOGY;

HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS;

EID: 66149166191     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.22881     Document Type: Article

References (63)

1. Ganem D, Schneider RJ. Hepadnaviridae and their replication. In: Knipe DM, Howley PM, Griffin DE, Martin MA, Lamb RA, Roizman B, et al, eds. Fields Virology. 4th ed. Philadelphia, PA: Lippincott-Raven Publishers; 2001.
2. Hollinger FB, Liang TJ. Hepatitis B virus. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, et al, eds. Fields Virology. 4th ed. Philadelphia, PA: Lippincott-Raven Publishers; 2001: 2971-3036.
3. Gavilanes F, Gonzales-Ros A, Peterson D. Structure of hepatitis B surface antigen: characterization of the lipid components and their association with the viral proteins. J Biol Chem 1982; 257: 7770-7777.
4. Gerlich W, Robinson WS. Hepatitis B virus contains protein attached to the 5' end of its complete strand. Cell 1980; 21: 801-811.
5. Hatton T, Zhou S, Standring DN. RNA- and DNA-binding activities in hepatitis B virus capsid protein: a model for their roles in viral replication. J Virol 1992; 66: 5232-5241.
6. Milich D, Liang TJ. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. HEPATOLOGY 2003; 38: 1075-1086.
7. Zhang Z, Torii N, Hu Z, Jacob J, Liang TJ. X-deficient woodchuck hepatitis virus mutants behave like attenuated viruses and induce protective immunity in vivo. J Clin Invest 2001; 108: 1523-1531.
8. Cross JC, Wen P, Rutter W. Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases. Proc Natl Acad Sci U S A 1993; 90: 8078-8082.
9. Hu Z, Zhang Z, Kim JW, Huang Y, Liang TJ. Altered proteolysis and global gene expression in hepatitis B virus X transgenic mouse liver. J Virol 2006; 80: 1405-1413.
10. Bouchard MJ, Schneider RJ. The enigmatic X gene of hepatitis B virus. J Virol 2004; 78: 12725-12734.
11. Seeger C, Ganem D, Varmus HE. Genetic and biochemical evidence for the hepatitis B virus replication strategy. Science 1986; 232: 477-485.
12. Yee J. A liver-specific enhancer in the core promoter region of human hepatitis B virus. Science 1989; 246: 658-670.
13. Tur-Kaspa R, Burk R, Shaul Y, Shafritz D. Hepatitis B virus DNA contains a glucocortcoid response element. Proc Natl Acad Sci U S A 1986; 83: 1627-1631.
14. Huang J, Liang TJ. A novel hepatitis B virus (HBV) genetic element with Rev response element-like properties that is essential for expression of HBV gene products. Mol Cell Biol 1993; 13: 7476-7486.
15. Klingmuller U, Schaller H. Hepadnavirus infection requires interaction between the viral pre-S domain and a specific hepatocellular receptor. J Virol 1993; 67: 7414-7422.
16. Breiner KM, Urban S, Schaller H. Carboxypeptidase D (gp180), a Golgi-resident protein, functions in the attachment and entry of avian hepatitis B viruses. J Virol 1998; 72: 8098-8104.
17. Kang HY, Lee S, Park SG, Yu J, Kim Y, Jung G. Phosphorylation of hepatitis B virus Cp at Ser87 facilitates core assembly. Biochem J 2006; 398: 311-317.
18. Kock J, Schilicht H-J. Analysis of the earliest steps of hepadnavirus replication genome repair after infectious entry into hepatocytes does not depend on viral polymerase activity. J Virol 1993; 67: 4867-4874.
19. Jean-Jean O, Weimer T, de Recondo AM, Will H, Rossignol JM. Internal entry of ribosomes and ribosomal scanning involved in hepatitis B virus P gene expression. J Virol 1989; 63: 5451-5454.
20. Persing DH, Varmus HE, Ganem D. The preS1 protein of hepatitis B virus is acylated at its amino terminus with myristic acid. J Virol 1987; 61: 1672-1677.
21. Pollack J, Ganem D. An RNA stem-loop structure directs hepatitis B virus genomic RNA encapsidation. J Virol 1993; 67: 3254-3263.
22. Will H, Reiser W, Weimer T, Pfaff E, Buscher M, Sprengel R, et al. Replication strategy of human hepatitis B virus. J Virol 1987; 61: 904-911.
23. Krugman S, Overby LR, Mushahwar IK, Ling CM, Frosner GG, Deinhardt F. Viral hepatitis, type B. Studies on natural history and prevention re-examined. N Engl J Med 1979; 300: 101-106.
24. Liang TJ, Ghany M. Hepatitis B e antigen-the dangerous endgame of hepatitis B. N Engl J Med 2002; 347: 208-210.
25. Tabor E, Hoofnagle JH, Barker LF, Pineda-Tamondong G, Nath N, Smallwood LA, et al. Antibody to hepatitis B core antigen in blood donors with a history of hepatitis. Transfusion 1981; 21: 366-371.
26. Perrillo RP, Chau KH, Overby LR, Decker RH. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses. Gastroenterology 1983; 85: 163-167.
27. Pawlotsky JM, Dusheiko G, Hatzakis A, Lau D, Lau G, Liang TJ, et al. Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach. Gastroenterology 2008; 134: 405-415.
28. Kuhns MC, Busch MP. New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods. Mol Diagn Ther 2006; 10: 77-91.
29. Loomba R, Liang TJ. Treatment of chronic hepatitis B. Antivir Ther 2007; 12(Suppl 3): H33-H41.
30. McMahon BJ, Alward WL, Hall DB, Heyward WL, Bender TR, Francis DP, et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985; 151: 599-603.
31. Barker LF, Murray R. Relationship of virus dose to incubation time of clinical hepatitis and time of appearance of hepatitis-associated antigen. Am J Med Sci 1972; 263: 27-33.
32. Berk PD, Popper H. Fulminant hepatic failure. Am J Gastroenterol 1978; 69: 349-400.
33. Hoofnagle JH, Carithers RL Jr, Shapiro C, Ascher N. Fulminant hepatic failure: summary of a workshop. HEPATOLOGY 1995; 21: 240-252.
34. McMahon The natural history of chronic hepaatitis B virus infection. HEPATOLOGY 2009; 49(suppl): S45-S55.
35. Weissberg JI, Andres LL, Smith CI, Weick S, Nichols JE, Garcia G, et al. Survival in chronic hepatitis B. An analysis of 379 patients. Ann Intern Med 1984; 101: 613-616.
36. Liaw YF, Tai DI, Chu CM, Chen TJ. The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. HEPATOLOGY 1988; 8: 493-496.
37. de Jongh FE, Janssen HL, de Man RA, Hop WC, Schalm SW, van Blankenstein M. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. Gastroenterology 1992; 103: 1630-1635.
38. Lok AS, Lai CL. Alpha-fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma. HEPATOLOGY 1989; 9: 110-115.
39. Spangenberg HC, Thimme R, Blum HE. Serum markers of hepatocellular carcinoma. Semin Liver Dis 2006; 26: 385-390.
40. Dienstag JL. Hepatitis B as an immune complex disease. Semin Liver Dis 1981; 1: 45-57.
41. Trepo C, Guillevin L. Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis. J Autoimmun 2001; 16: 269-274.
42. Alpert E, Isselbacher KJ, Schur PH. The pathogenesis of arthritis associated with viral hepatitis. Complement-component studies. N Engl J Med 1971; 285: 185-189.
43. Gocke DJ, Hsu K, Morgan C, Bombardieri S, Lockshin M, Christian CL. Association between polyarteritis and Australia antigen. Lancet 1970; 2: 1149-1153.
44. Lai KN, Li PK, Lui SF, Au TC, Tam JS, Tong KL, et al. Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med 1991; 324: 1457-1463.
45. Takekoshi Y, Tanaka M, Shida N, Satake Y, Saheki Y, Matsumoto S. Strong association between membranous nephropathy and hepatitis-B surface antigenaemia in Japanese children. Lancet 1978; 2: 1065-1068.
46. Lai KN, Lai FM. Clinical features and the natural course of hepatitis B virus-related glomerulopathy in adults. Kidney Int Suppl 1991; 35: S40-S45.
47. Ishimaru Y, Ishimaru H, Toda G, Baba K, Mayumi M. An epidemic of infantile papular acrodermatitis (Gianotti's disease) in Japan associated with hepatitis-B surface antigen subtype ayw. Lancet 1976; 1: 707-709.
48. Liang TJ, Baruch Y, Ben-Porath E, Enat R, Bassan L, Brown NV, et al. Hepatitis B virus infection in patients with idiopathic liver disease. HEPATOLOGY 1991; 13: 1044-1051.
49. Liang TJ, Blum HE, Wands JR. Characterization and biological properties of a hepatitis B isolated from a patient without HBV serologic markers. HEPATOLOGY 1990; 12: 204-212.
50. Paterlini P, Gerken G, Nakajima E, Terre S, D'Errico A, Grigioni W, et al. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 1990; 323: 80-85.
51. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996; 2: 1104-1108.
52. Yotsuyanagi H, Yasuda K, Iino S, Moriya K, Shintani Y, Fujie H, et al. Persistent viremia after recovery from self-limited acute hepatitis B. HEPATOLOGY 1998; 27: 1377-1382.
53. Korba BE, Cote PJ, Wells FV, Baldwin B, Popper H, Purcell RH, et al. Natural history of woodchuck hepatitis virus infections during the course of experimental viral infection: molecular virologic features of the liver and lymphoid tissues. J Virol 1989; 63: 1360-1370.
54. Thiers V, Nakajima E, Kremsdorf D, Mack D, Schellekens H, Driss F, et al. Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet 1988; 2: 1273-1276.
55. Dickson RC, Everhart JE, Lake JR, Wei Y, Seaberg EC, Wiesner RH, et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology 1997; 113: 1668-1674.
56. Blanpain C, Knoop C, Delforge ML, Antoine M, Peny MO, Liesnard C, et al. Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies: report on three cases and review of the literature. Transplantation 1998; 66: 883-886.
57. Lok AS, Liang RH, Chiu EK, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991; 100: 182-188.
58. Hui CK, Cheung WW, Zhang HY, Au WY, Yueng YH, Leung AY, et al. Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy. Gastroenterology 2006; 131: 59-68.
59. Loomba R, Rowley A, Wesley R, Liang TJ, Hoofnagle JH, Pucino F, et al. Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy. Ann Intern Med 2008; 148: 519-528.
60. Blum HE, Galun E, Liang TJ, von Weizsacker F, Wands JR. Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication. J Virol 1991; 65: 1836-1842.
61. Hou J, Karayiannis P, Waters J, Luo K, Liang C, Thomas HC. A unique insertion in the S gene of surface antigen-negative hepatitis B virus Chinese carriers. HEPATOLOGY 1995; 21: 273-278.
62. Kato J, Hasegawa K, Torii N, Yamauchi K, Hayashi N. A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B. HEPATOLOGY 1996; 23: 389-395.
63. Yamamoto K, Horikita M, Tsuda F, Itoh K, Akahane Y, Yotsumoto S, et al. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol 1994; 68: 2671-2676.